LoginRegister
    AstraZeneca scores win in race to treat ovarian cancerAstraZeneca scores win in race to treat ovarian cancer
    Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With NarcolepsyHarmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For...
    Cipla shareholders approve raising up to Rs 3,000 crCipla shareholders approve raising up to Rs 3,000 cr
    Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use in TAVREdwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use in TAVR
    Novartis exec sold shares before drug data manipulation made publicNovartis exec sold shares before drug data manipulation made public
    VG Somani replaces Eswara Reddy as new Drugs Controller General of IndiaVG Somani replaces Eswara Reddy as new Drugs Controller General of India
    NPPA fixes price of 3 drug formulations; Check out detailsNPPA fixes price of 3 drug formulations; Check out details
    Sun Pharma collaborates with CMS to develop, commercialize 7 generic products in ChinaSun Pharma collaborates with CMS to develop, commercialize 7 generic products in China
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditionsLupin gets USFDA approval for generic version of Westcort cream to treat skin conditions
    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per yearAbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year
    Domestic Pharma sales bounce back after two months of decline: BloombergDomestic Pharma sales bounce back after two months of decline: Bloomberg
    Wockhardt Q1 net loss shrinks to Rs 45 crore from previous fiscal loss of Rs 89.18 croreWockhardt Q1 net loss shrinks to Rs 45 crore from previous fiscal loss of Rs 89.18 crore
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X